Stoke Therapeutics, Inc. - STOK
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q2 2026
· Q1 2026
Value (USD)
Total reported value ($000)
$2.549B
QoQ value delta ($000)
+$221.6M
(+9.52%)
Implied price effect (QoQ)
+0.5%
Shares
Total shares
77,914,950
QoQ shares delta
+6,417,959
(+8.98%)
Total shares held by funds (by quarter)
Market chart (STOK)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q2 2026)
Top 25 only
Full list
Partial Q2 2026 data: 198 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| BlackRock, Inc. | 192,307 | 5,877,357 | 0.0% |
| RTW INVESTMENTS, LP | 184,001 | 5,623,525 | 1.57% |
| FMR LLC | 173,844 | 5,313,100 | 0.01% |
| Lynx1 Capital Management LP | 132,136 | 4,038,404 | 15.27% |
| Redmile Group, LLC | 129,110 | 3,945,920 | 8.67% |
| WELLINGTON MANAGEMENT GROUP LLP | 115,151 | 3,519,301 | 0.02% |
| MORGAN STANLEY | 112,975 | 3,452,795 | 0.01% |
| BAKER BROS. ADVISORS LP | 109,176 | 3,336,697 | 0.55% |
| TORONTO DOMINION BANK | 103,829 | 3,173,258 | 0.12% |
| STATE STREET CORP | 93,325 | 2,852,240 | 0.0% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 87,093 | 2,661,739 | 0.01% |
| VANGUARD CAPITAL MANAGEMENT LLC | 84,644 | 2,586,937 | 0.0% |
| BVF INC/IL | 83,356 | 2,547,557 | 2.13% |
| T. Rowe Price Investment Management, Inc. | 79,024 | 2,415,139 | 0.05% |
| Siren, L.L.C. | 65,287 | 1,995,347 | 1.32% |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 59,664 | 1,823,500 | 0.62% |
| Jupiter Topco LLC | 59,358 | 1,814,408 | 0.02% |
| JANUS HENDERSON GROUP PLC | 52,455 | 1,612,781 | 0.03% |
| GEODE CAPITAL MANAGEMENT, LLC | 49,884 | 1,524,309 | 0.0% |
| Assenagon Asset Management S.A. | 36,920 | 1,128,388 | 0.05% |
| DIMENSIONAL FUND ADVISORS LP | 33,173 | 1,013,911 | 0.01% |
| Polar Capital Holdings Plc | 27,279 | 833,716 | 0.06% |
| EcoR1 Capital, LLC | 24,049 | 735,000 | 1.17% |
| MPM BioImpact LLC | 23,666 | 723,314 | 1.44% |
| Opaleye Management Inc. | 22,904 | 700,000 | 2.07% |